Hainan Huluwa Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 3/6
Hainan Huluwa Pharmaceutical Group has a total shareholder equity of CN¥1.2B and total debt of CN¥1.3B, which brings its debt-to-equity ratio to 110.4%. Its total assets and total liabilities are CN¥3.1B and CN¥1.9B respectively. Hainan Huluwa Pharmaceutical Group's EBIT is CN¥189.6M making its interest coverage ratio 10.1. It has cash and short-term investments of CN¥522.7M.
Key information
110.4%
Debt to equity ratio
CN¥1.28b
Debt
Interest coverage ratio | 10.1x |
Cash | CN¥522.69m |
Equity | CN¥1.16b |
Total liabilities | CN¥1.90b |
Total assets | CN¥3.06b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 605199's short term assets (CN¥1.4B) exceed its short term liabilities (CN¥1.1B).
Long Term Liabilities: 605199's short term assets (CN¥1.4B) exceed its long term liabilities (CN¥818.7M).
Debt to Equity History and Analysis
Debt Level: 605199's net debt to equity ratio (65.3%) is considered high.
Reducing Debt: 605199's debt to equity ratio has increased from 16% to 110.4% over the past 5 years.
Debt Coverage: 605199's debt is not well covered by operating cash flow (2.2%).
Interest Coverage: 605199's interest payments on its debt are well covered by EBIT (10.1x coverage).